NEW YORK (GenomeWeb) – Vanderbilt University Medical Center today announced a collaboration with BioReference Laboratories for tumor profiling in cancer care.

Under the terms of the multiyear agreement, the partners will develop a next-generation sequencing panel for tumors and hematologic malignancies, aiming to make it available in 2016 for use in clinical oncology. The panel is expected to comprise more than 300 genes and will target SNPs, insertions and deletions, CNVs, and gene fusions in regions of the genome that are druggable.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The UK's Human Fertility and Embryology Authority calls for consumer genetic testing companies to warn customers that testing could uncover family secrets, according to the Guardian.

The New York Times reports that United Nations delegates have been discussing how to govern the genetic resources of the deep sea.

Researchers have transplanted edited cells into mice that appear to combat cocaine addiction, New Scientist reports.

In PNAS this week: analysis of proteolytic enzymes secreted by circulating tumor cells, phylogenetic study of Fv1 evolution, and more.